CD47 and neoplasm: The functional markers demonstrated expression in cellular subsets similar to that commonly reported in the literature; T cells and some tumor clusters expressed markers for immune checkpoints, while tumor-associated fibroblasts (CD47+ CD56+ cells) and some tumor cell subsets (CD47+ FOLR1+ cells) did not demonstrate any increased expression of functional markers.